Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.790
+0.030 (0.63%)
At close: Nov 6, 2026, 4:00 PM EST
4.830
+0.040 (0.84%)
After-hours: Nov 6, 2026, 7:30 PM EST

Champions Oncology Revenue

Champions Oncology had revenue of $15.23M in the quarter ending July 31, 2026, with 8.84% growth. This brings the company's total for the last twelve months to $60.66M, up 6.65% year-over-year. In the fiscal year ending April 30, 2026, Champions Oncology had annual revenue of $59.43M with 4.36% growth. That makes Champions Oncology the 26,502nd largest company in the world by revenue and 3,630th in the United States.

Revenue (ttm)
$60.66M
Revenue Growth
+6.65%
P/S Ratio
1.10
Revenue / Employee
$283,467
Employees
214
Market Cap
66.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 202659.43M2.48M4.36%
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 202032.12M5.06M18.68%
Apr 30, 201927.07M6.83M33.72%
Apr 30, 201820.24M4.83M31.34%
Apr 30, 201715.41M--
Apr 30, 2016---
Apr 30, 2015---
Apr 30, 2014---
Apr 30, 2013---
Apr 30, 2012---
Apr 30, 2011---
Apr 30, 2010---
Apr 30, 20093.71M2.31M165.00%
Apr 30, 20081.40M--
Apr 30, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Fortress Biotech68.47M
Coya Therapeutics8.02M
Nutriband1.62M
MediciNova920.48K
Cardiff Oncology508.00K
Revenue Rankings